Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
[Online ahead of print]

The Effects of Melatonin on Signaling Pathways and Molecules Involved in Glioma

Affiliations
Review

The Effects of Melatonin on Signaling Pathways and Molecules Involved in Glioma

Foroogh Neamati et al. Fundam Clin Pharmacol.

Abstract

Glioblastoma is one of the most common brain tumors with high invasion and malignancy. Despite extensive research in this area and the use of new and advanced therapies, the survival rate in this disease is very low. In addition, resistance to treatment has also been observed in this disease. One of the reasons for rapid progression and failure in treatment for this disease is the presence of a class of cells with high proliferation and high differentiation, a class called glioblastoma stem-like cells shown as being the source of glioblastoma tumors. It has been reported that several oncogenes are expressed in this disease. One important issue in recognizing the pathogenesis of this disease, and which could improve the treatment process, is the identification of involved oncogenes as well as molecules that affect the reduction of the expression of these oncogenes. Melatonin regulates the biological rhythm and inhibits the proliferation of malignant glioma cells due to antioxidant and anti-apoptotic effects. Melatonin has been considered in biological processes and in signaling pathways involved in the development of glioma. The aim of this review is to investigate the effects of melatonin on signaling pathways and molecules involved in the progression of glioma.

Keywords: glioma; melatonin; signaling pathways.

Similar articles

See all similar articles

References

    1. Munksgaard Thoren M., Chmielarska Masoumi K., Krona C. et al. Integrin alpha10, a novel therapeutic target in glioblastoma, regulates cell migration, proliferation, and survival. Cancers (2019) 11 E587.
    1. Masoudi M.S., Mehrabian E., Mirzaei H. MiR-21: a key player in glioblastoma pathogenesis. J. Cell. Biochem. (2018) 119 1285-1290.
    1. Li Y.P., Dai W.M., Huang Q. et al. Effects of microRNA-26b on proliferation and invasion of glioma cells and related mechanisms.. Mol. Med. Rep. (2017) 16 4165-4170.
    1. Saadatpour L., Fadaee E., Fadaei S. et al. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther. (2016) 23 415-418.
    1. Cheng T., Xu Y. Effects of enhancer of zeste homolog 2 (EZH2) expression on brain glioma cell proliferation and tumorigenesis. Med. Sci. Monit. (2018) 24 7249-7255.

LinkOut - more resources

Feedback